Isatuximab monotherapy in patients with refractory T‐acute lymphoblastic leukemia or T‐lymphoblastic lymphoma: Phase 2 study

The poor prognosis of acute T‐cell lymphoblastic leukemia (T‐ALL) and T‐cell lymphoblastic lymphoma (T‐LBL) in older adults and patients with relapsed/refractory illness is an unmet clinical need, as there is no defined standard of care and there are few treatment options. Abnormally elevated CD38 e...

Descripción completa

Detalles Bibliográficos
Autores principales: Boissel, Nicolas, Chevallier, Patrice, Doronin, Vadim, Griskevicius, Laimonas, Maschan, Alexey, McCloskey, James, Rambaldi, Alessandro, Rossi, Giuseppe, Sokolov, Andrey, Wartiovaara‐Kautto, Ulla, Oprea, Corina, Abbadessa, Giovanni, Gosselin, Alice, Macé, Sandrine, Thomas, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894690/
https://www.ncbi.nlm.nih.gov/pubmed/35106962
http://dx.doi.org/10.1002/cam4.4478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894690/
https://www.ncbi.nlm.nih.gov/pubmed/35106962
http://dx.doi.org/10.1002/cam4.4478

Ejemplares similares